• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Fierce Pharma Homepage

Makary
Favicon Fierce Pharma

FDA commissioner pledges crackdown on compounding practices

With online health company Hims & Hers opening a new front in the GLP-1 compounding showdown, the United States’ top drug regulator has taken notice.
Fraiser Kansteiner Feb 6, 2026 9:59am
TrumpRx
Favicon Fierce Pharma

US government launches TrumpRx drug purchasing portal

Feb 6, 2026 8:00am
Grouping of tiles with human figures on them being separated representing layoffs

Genentech cut at least 489 jobs last year, new filing reveals

Feb 6, 2026 1:38pm
IPO initial public offering

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

Feb 6, 2026 4:04am
Astellas
Favicon Fierce Pharma

Astellas lifts forecast as Vyloy surge counters trial miss

Feb 5, 2026 11:00am
new york stock exchange
Favicon Fierce Pharma

Veradermics locks in $256M IPO, shares spike

Feb 5, 2026 10:01am
More News
Fierce Pharma

FDA’s rare pediatric voucher program revived by funding bill

Feb 4, 2026 3:12pm

Charles River to close Maryland CDMO site, lay off 20 staffers

Feb 3, 2026 12:20pm

FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad

Feb 3, 2026 11:40am
Fierce Pharma

Thermo Fisher winds down Boston area plant

Feb 2, 2026 12:22pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings